Caution with regard to the efficacy of interferon alfa-2b in the treatment of giant hemangiomas.
Léauté-Labrèze
C
C
Taïeb
A
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins